QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

Clinical trial NCT07141186 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07141186
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Cervical Cancer Metastatic Cervical Cancer Recurrent Cervical Adenocarcinoma Cervical Cancer Squamous Cell

Start date: 2025-10-01
Primary completion: 2027-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.